Viepax 37.5 mg is a prescription antidepressant manufactured by the Israeli pharmaceutical company Dexcel Pharma, formulated with Venlafaxine. Belonging to the class of Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Viepax is widely prescribed to treat major depressive disorder, generalized anxiety disorder (GAD), social anxiety disorder, and panic disorder.

Indications: Viepax 37.5 mg is used for:

• Treatment and prevention of major depressive disorder (MDD)

• Management of generalized anxiety disorder (GAD)

• Treatment of social anxiety disorder (social phobia)

• Control of panic disorder with or without agoraphobia

Reasons for Use:

• Persistent low mood, fatigue, loss of interest, and emotional numbness

• Excessive, uncontrollable worry and chronic nervousness

• Recurrent panic attacks accompanied by physical symptoms of anxiety

• Initiating SNRI therapy with a low-dose titration scheme under medical supervision

Key Features:

• Active ingredient — Venlafaxine 37.5 mg per tablet

• Dual-action mechanism: potent inhibitor of neuronal serotonin and norepinephrine reuptake

• Ideal 37.5 mg starting strength for gradual dosage adjustment and optimal tolerance

• Standard pack containing 28 tablets (28 Tablets)

• Manufactured according to rigorous pharmaceutical standards by Dexcel Pharma in Israel

Dosage Form: Viepax — Tablets, 37.5 mg (pack of 28 tablets)

Manufacturer: Dexcel Pharma

Active Ingredients:

• Venlafaxine — 37.5 mg

#Viepax #Venlafaxine #DexcelPharma #Antidepressant #SNRI #AnxietyRelief #DepressionTreatment #PanicDisorder #IsraeliMeds #PharmacyIsrael